| De novo methyltransferases: Potential players in diseases and new directions for targeted therapy P Saravanaraman, M Selvam, C Ashok, L Srijyothi, S Baluchamy Biochimie 176, 85-102, 2020 | 23 | 2020 |
| A feedback regulation of CREB activation through the CUL4A and ERK signaling C Ashok, S Owais, L Srijyothi, M Selvam, S Ponne, S Baluchamy Medical Oncology 36 (2), 20, 2019 | 13 | 2019 |
| CREB acts as a common transcription factor for major epigenetic repressors; DNMT3B, EZH2, CUL4B and E2F6 C Ashok, M Selvam, S Ponne, PK Parcha, KMP Raja, S Baluchamy Medical Oncology 37 (8), 68, 2020 | 8 | 2020 |
| N-terminal truncations of human bHLH transcription factor Twist1 leads to the formation of aggresomes G Govindarajalu, M Selvam, E Palchamy, S Baluchamy Molecular and cellular biochemistry 439, 75-85, 2018 | 6 | 2018 |
| microRNA-150 targets major epigenetic repressors and inhibits cell proliferation M Selvam, V Bandi, S Ponne, C Ashok, S Baluchamy Experimental Cell Research 415 (1), 113110, 2022 | 3 | 2022 |
| FLT3 tyrosine kinase inhibition modulates PRC2 and promotes differentiation in acute myeloid leukemia PJ Sung, M Selvam, SS Riedel, HM Xie, K Bryant, B Manning, ... Leukemia 38 (2), 291-301, 2024 | 2 | 2024 |
| Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapy D Frank, PK Patnana, J Vorwerk, L Mao, LM Gopal, N Jung, T Hennig, ... Blood 142 (25), 2175-2191, 2023 | 2 | 2023 |
